Portola Pharmaceuticals, Inc (PTLA) Covered Calls

Portola Pharmaceuticals, Inc covered calls Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

You can sell covered calls on Portola Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PTLA (prices last updated Fri 4:16 PM ET):

Portola Pharmaceuticals, Inc (PTLA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
20.68 -0.12 20.02 21.99 1.0M - 0.0B
Covered Calls For Portola Pharmaceuticals, Inc (PTLA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 20 1.55 20.44 -2.2% -53.5%
Jan 18 20 2.70 19.29 3.7% 31.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Portola Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation. Its development-stage portfolio consists of the compounds including Betrixaban, a novel oral once-daily inhibitor of Factor Xa in phase three clinical trials for extended duration prophylaxis, or preventive treatment of a form of thrombosis known as venous thromboembolism, in acute medically ill patients; Andexanet alfa, a recombinant protein designed to reverse anticoagulant activity in patients treated with a Factor Xa inhibitor; and Cerdulatinib, an orally available kinase inhibitor that inhibits spleen tyrosine kinase and janus kinases, enzymes that regulate important signaling pathways. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.